Brachytherapy devices market to reach $534.2m by 2031

By application, the prostate cancer segment dominated in 2024.

The brachytherapy devices market is expected to reach $534.2m by 2031 at a compound annual growth rate of 6.7%, according to The Insight Partners.

The sector’s expansion is attributed to the increasing incidence of cancer, the ageing population, and technological advancements.

“Important technological advancements include the creation of high-dose rate and low-dose rate machines, which provide more accurate radiation delivery,” the report said.

By application, the prostate cancer segment dominated the market in 2024.

By end user, the hospitals and speciality clinics segment led the market in the same period.